TARICK ELAYAN: Open Payments
NPI 1922747054 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 76 payments from 13 companies in 2025. Trend: 2023 $579 · 2024 $904 · 2025 $2,044
Food & beverage: $2,044
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $814 |
| AstraZeneca Pharmaceuticals LP | 22 | $683 |
| CeQur Corporation | 1 | $161 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Novo Nordisk Inc | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: CAPLYTA, CeQur Simplicity, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, Wegovy, VRAYLAR, ELIQUIS.
Industry payments across MI — which companies pay providers there.
